<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2023-02-07T13:09:22Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3070741" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:3070741</identifier>
        <datestamp>2011-04-11</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-id journal-id-type="pmc">plosone</journal-id>
              <journal-title-group>
                <journal-title>PLoS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC3070741</article-id>
              <article-id pub-id-type="pmcid">PMC3070741</article-id>
              <article-id pub-id-type="pmc-uid">3070741</article-id>
              <article-id pub-id-type="pmid">21483704</article-id>
              <article-id pub-id-type="pmid">21483704</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-10-06545</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0018001</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v2">
                  <subject>Medicine</subject>
                  <subj-group>
                    <subject>Clinical Research Design</subject>
                    <subj-group>
                      <subject>Clinical Trials</subject>
                    </subj-group>
                  </subj-group>
                  <subj-group>
                    <subject>Mental Health</subject>
                    <subj-group>
                      <subject>Psychiatry</subject>
                      <subj-group>
                        <subject>Anxiety Disorders</subject>
                      </subj-group>
                    </subj-group>
                    <subj-group>
                      <subject>Psychology</subject>
                      <subj-group>
                        <subject>Clinical Psychology</subject>
                      </subj-group>
                    </subj-group>
                    <subj-group>
                      <subject>Therapies</subject>
                      <subj-group>
                        <subject>Psychotherapy</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Internet-Based Cognitive Behavior Therapy vs. Cognitive Behavioral
Group Therapy for Social Anxiety Disorder: A Randomized Controlled
Non-inferiority Trial</article-title>
                <alt-title alt-title-type="running-head">Internet-Based CBT vs. Group CBT for SAD -
A RCT</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hedman</surname>
                    <given-names>Erik</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="corresp" rid="cor1">
                    <sup>*</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Andersson</surname>
                    <given-names>Gerhard</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff2">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ljótsson</surname>
                    <given-names>Brjánn</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Andersson</surname>
                    <given-names>Erik</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rück</surname>
                    <given-names>Christian</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Mörtberg</surname>
                    <given-names>Ewa</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff3">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lindefors</surname>
                    <given-names>Nils</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">
                    <sup>1</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="aff1">
                <label>1</label>
                <addr-line>Department of Clinical Neuroscience, Division
of Psychiatry, Karolinska Institutet, Stockholm, Sweden</addr-line>
              </aff>
              <aff id="aff2">
                <label>2</label>
                <addr-line>Department of Behavioural Sciences and
Learning, Swedish Institute for Disability Research, Linköping University,
Linköping, Sweden</addr-line>
              </aff>
              <aff id="aff3">
                <label>3</label>
                <addr-line>Department of Psychology, Stockholm
University, Stockholm, Sweden</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>García</surname>
                    <given-names>Antonio Verdejo</given-names>
                  </name>
                  <role>Editor</role>
                  <xref ref-type="aff" rid="edit1"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">University of Granada, Spain</aff>
              <author-notes>
                <corresp id="cor1">* E-mail: <email>erik.hedman.2@ki.se</email></corresp>
                <fn fn-type="con">
                  <p>Conceived and designed the experiments: EH GA BL EA CR EM NL. Analyzed the
data: EH GA BL EA CR EM NL. Wrote the paper: EH GA BL EA CR EM NL.</p>
                </fn>
              </author-notes>
              <pub-date pub-type="collection">
                <year>2011</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>25</day>
                <month>3</month>
                <year>2011</year>
              </pub-date>
              <pub-date pub-type="ecorrected">
                <day>04
</day>
                <month>4</month>
                <year>2011</year>
              </pub-date>
              <volume>6</volume>
              <issue>3</issue>
              <elocation-id>e18001</elocation-id>
              <history>
                <date date-type="received">
                  <day>11</day>
                  <month>12</month>
                  <year>2010</year>
                </date>
                <date date-type="accepted">
                  <day>17</day>
                  <month>2</month>
                  <year>2011</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Hedman et al.</copyright-statement>
                <copyright-year>2011</copyright-year>
                <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
                  <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p>
                </license>
              </permissions>
              <abstract>
                <sec>
                  <title>Background and Aims</title>
                  <p>Cognitive behavioral group therapy (CBGT) is an effective, well-established,
but not widely available treatment for social anxiety disorder (SAD).
Internet-based cognitive behavior therapy (ICBT) has the potential to
increase availability and facilitate dissemination of therapeutic services
for SAD. However, ICBT for SAD has not been directly compared with in-person
treatments such as CBGT and few studies investigating ICBT have been
conducted in clinical settings. Our aim was to investigate if ICBT is at
least as effective as CBGT for SAD when treatments are delivered in a
psychiatric setting.</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p>We conducted a randomized controlled non-inferiority trial with allocation to
ICBT (n = 64) or CBGT (n = 62)
with blinded assessment immediately following treatment and six months
post-treatment. Participants were 126 individuals with SAD who received CBGT
or ICBT for a duration of 15 weeks. The Liebowitz Social Anxiety Scale
(LSAS) was the main outcome measure. The following non-inferiority margin
was set: following treatment, the lower bound of the 95 % confidence
interval (CI) of the mean difference between groups should be less than 10
LSAS-points.</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p>Both groups made large improvements. At follow-up, 41 (64%)
participants in the ICBT group were classified as responders (95% CI,
52%–76%). In the CBGT group, 28 participants
(45%) responded to the treatment (95% CI,
33%–58%). At post-treatment and follow-up respectively,
the 95 % CI of the LSAS mean difference was 0.68–17.66
(Cohen’s <italic>d</italic> between group = 0.41)
and −2.51–15.69 (Cohen’s <italic>d</italic> between
group = 0.36) favoring ICBT, which was well within the
non-inferiority margin. Mixed effects models analyses showed no significant
interaction effect for LSAS, indicating similar improvement across
treatments (<italic>F</italic> = 1.58;
df = 2, 219;
<italic>p</italic> = .21).</p>
                </sec>
                <sec>
                  <title>Conclusions</title>
                  <p>ICBT delivered in a psychiatric setting can be as effective as CBGT in the
treatment of SAD and could be used to increase availability to CBT.</p>
                </sec>
                <sec>
                  <title>Trial Registration</title>
                  <p>ClinicalTrials.gov <ext-link ext-link-type="uri" xlink:href="http://clinicaltrials.gov/ct2/show/NCT00564967">NCT00564967</ext-link>
</p>
                </sec>
              </abstract>
              <counts>
                <page-count count="10"/>
              </counts>
            </article-meta>
          </front>
          <body>
            <sec id="s1">
              <title>Introduction</title>
              <p>Social anxiety disorder (SAD), or social phobia, is characterized by a persistent and
debilitating fear of being evaluated by others. SAD typically has an early onset
<xref rid="pone.0018001-Kessler1" ref-type="bibr">[1]</xref>, runs a
chronic course <xref rid="pone.0018001-Reich1" ref-type="bibr">[2]</xref>,
is one of the most prevalent anxiety disorder in the western world <xref rid="pone.0018001-Ruscio1" ref-type="bibr">[3]</xref>, and is
associated with functional impairment <xref rid="pone.0018001-Schneier1" ref-type="bibr">[4]</xref>. Cognitive behavioral group
therapy (CBGT) for SAD has proven to be effective in several randomized controlled
trials (RCTs) over the last 20 years. Results have shown that CBGT is superior to
psychological <xref rid="pone.0018001-Heimberg1" ref-type="bibr">[5]</xref> and pill placebo and that it can be as effective as
pharmacological treatment with SSRIs <xref rid="pone.0018001-Heimberg2" ref-type="bibr">[6]</xref>, making it the most
established psychological treatment for SAD <xref rid="pone.0018001-JorstadStein1" ref-type="bibr">[7]</xref>, <xref rid="pone.0018001-Ponniah1" ref-type="bibr">[8]</xref>. However, CBGT is available to
only a few due to a lack of trained therapists <xref rid="pone.0018001-Shapiro1" ref-type="bibr">[9]</xref>. While individually
administered CBT has demonstrated large effects <xref rid="pone.0018001-Clark1" ref-type="bibr">[10]</xref> and might be more efficacious
than CBGT <xref rid="pone.0018001-Stangier1" ref-type="bibr">[11]</xref>,
<xref rid="pone.0018001-Mrtberg1" ref-type="bibr">[12]</xref>, this
treatment format is even more dependent on the availability of trained
therapists.</p>
              <p>More recently, guided Internet-based CBT (ICBT) has shown promising results in RCTs
conducted by three independent research groups <xref rid="pone.0018001-Carlbring1" ref-type="bibr">[13]</xref>, <xref rid="pone.0018001-Andersson1" ref-type="bibr">[14]</xref>, <xref rid="pone.0018001-Tillfors1" ref-type="bibr">[15]</xref>, <xref rid="pone.0018001-Furmark1" ref-type="bibr">[16]</xref>, <xref rid="pone.0018001-Berger1" ref-type="bibr">[17]</xref>, <xref rid="pone.0018001-Titov1" ref-type="bibr">[18]</xref>. The treatment entails the same
components as conventional CBT, such as exposure to feared situations, but is
delivered over the Internet with therapist contact via an online messaging system
resembling e-mail <xref rid="pone.0018001-Andersson1" ref-type="bibr">[14]</xref>. Evidence has shown that improvements made during ICBT
are persistent <xref rid="pone.0018001-Carlbring2" ref-type="bibr">[19]</xref>. ICBT has some important advantages over live treatment.
First, it is not restricted in time or to a specific geographic location (i.e.,
patients as well as therapists can work with the treatment at any time or place they
wish). Second, since ICBT demands less therapist time, ICBT therapists can treat
significantly more patients than possible with CBGT <xref rid="pone.0018001-Andersson2" ref-type="bibr">[20]</xref>, <xref rid="pone.0018001-Barak1" ref-type="bibr">[21]</xref>. Consequently, ICBT has the
potential to dramatically increase availability of CBT.</p>
              <p>Although ICBT for SAD has demonstrated effects in line with CBGT, the current
evidence holds a number of limitations. There has been no comparison to conventional
CBT, such as CBGT, and most studies have relied solely on self-report instruments as
measures of treatment outcome. In addition, most studies have been conducted in
university settings, which might have a different impact on treatment experience and
outcome compared to receiving care at a psychiatric clinic. Although one study has
indicated that the characteristics of Internet clinic patients could be similar to
those of outpatient clinics <xref rid="pone.0018001-Titov2" ref-type="bibr">[22]</xref>, the research field would benefit from a trial conducted
in a psychiatric context. Finally, diagnostic procedures may be more clinically
valid when conducted in a clinical setting. This has not been the case in the
previous studies where only telephone interviews or self-report have been used.</p>
              <p>In summary, more empirical evidence is needed before ICBT can be validly employed in
a psychiatric context. As CBGT is an effective gold standard treatment appropriate
for use as a benchmark <xref rid="pone.0018001-Hunsley1" ref-type="bibr">[23]</xref>, the necessary evidence to validate ICBT is to
demonstrate non-inferiority (i.e., equal efficacy) to CBGT <xref rid="pone.0018001-McAlister1" ref-type="bibr">[24]</xref>. The aim of the present
study was to determine whether ICBT is as effective as CBGT for patients with SAD
when administered in a psychiatric setting. We hypothesized that ICBT would be at
least as effective as CBGT in reducing social anxiety. We also predicted that the
two treatments would be equal on secondary outcome measures of depressive symptoms,
general anxiety, quality of life, and global functioning.</p>
            </sec>
            <sec sec-type="methods" id="s2">
              <title>Methods</title>
              <sec id="s2a">
                <title>Trial design</title>
                <p>The protocol for this trial and supporting CONSORT checklist are available as
supporting information; see <xref ref-type="supplementary-material" rid="pone.0018001.s002">Checklist S1</xref> and <xref ref-type="supplementary-material" rid="pone.0018001.s001">Protocol
S1</xref>. This was a non-inferiority trial within the context of a parallel
group study with unrestricted randomisation in 1∶1 ratio conducted in
Sweden. Outcome assessors were blind to treatment status.</p>
              </sec>
              <sec id="s2b">
                <title>Recruitment and selection</title>
                <p>Recruitment for the study took place between 2007 and 2009. Participants were
recruited by referral from primary care physicians and psychiatrists, and by
self-referral to the psychiatric clinic at the Karolinska University Hospital in
Stockholm, Sweden. Information about the treatment and the study was published
on the official web page of the clinic (<ext-link ext-link-type="uri" xlink:href="http://www.internetpsykiatri.se">www.internetpsykiatri.se</ext-link>). There were no advertisements in
newspapers or other media. The study protocol was approved by the Regional
Ethical Review Board in Stockholm (Karolinska Institutet) and written informed
consent was obtained from all participants after a detailed description of the
study had been given.</p>
                <p>To be eligible for inclusion potential participants had to meet the following
criteria: (a) fulfill the DSM-IV <xref rid="pone.0018001-American1" ref-type="bibr">[25]</xref> criteria of social
anxiety disorder as assessed using the Structured Clinical Interview for DSM-IV
axis I disorders (SCID-I) <xref rid="pone.0018001-First1" ref-type="bibr">[26]</xref>, (b) agree to undergo no other psychological
treatment for the duration of the study, (c) have no history of CBT for the last
four years, (d) have constant dosage two months prior to treatment of any
prescribed medication for anxiety or depression and agree to keep dosage
constant throughout the study, (e) have a primary diagnosis of SAD as assessed
by the interviewing psychiatrist (individuals with comorbid disorders according
to the Mini International Neuropsychiatric Interview (MINI) <xref rid="pone.0018001-Sheehan1" ref-type="bibr">[27]</xref> were not
excluded), (f) not currently meet the diagnostic criteria for substance abuse
(g) have no history of psychosis or bipolar disorder, (h) not score &gt;20 on
the Montgomery Åsberg Depression Rating Scale-self report (MADRS-S) <xref rid="pone.0018001-Svanborg1" ref-type="bibr">[28]</xref>, (j) if
criteria for major depression were met, have a score of less than 4 of 6 on the
suicide ideation item of MADRS-S, and (k) not meet criteria for any personality
disorders within cluster A (e.g. paranoid personality disorder) or B (e.g.
antisocial personality disorder), which could interfere with the therapeutic
process in group therapy.</p>
                <p>During the first stage of the recruitment process, potential participants were
asked to complete the Social Phobia Screening Questionnaire (SPSQ) <xref rid="pone.0018001-Furmark2" ref-type="bibr">[29]</xref>, MADRS-S,
the Alcohol Use Disorders Identification Test (AUDIT) <xref rid="pone.0018001-Saunders1" ref-type="bibr">[30]</xref>, and the Drug User
Disorders Identification Test (DUDIT) <xref rid="pone.0018001-Berman1" ref-type="bibr">[31]</xref>. In the second stage,
participants were invited to attend an interview with a psychiatrist at the
Karolinska University Hospital to confirm the SAD diagnosis and establish
whether they met the remaining inclusion criteria (b-k). The psychiatrists
conducting the assessments had more than 10 years of experience working with
structured diagnostic interviews and had undergone extensive training in the use
of the primary outcome measure, as well as of the SCID and the MINI. Two hundred
thirty applicants completed the screening questionnaires and underwent the
interview. Of those, 126 met all 10 inclusion criteria. <xref ref-type="fig" rid="pone-0018001-g001">Figure 1</xref> shows the participant flow
throughout the trial. Demographic information for participants is presented in
<xref ref-type="table" rid="pone-0018001-t001">Table 1</xref>.</p>
                <fig id="pone-0018001-g001" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0018001.g001</object-id>
                  <label>Figure 1</label>
                  <caption>
                    <title>Participant flow and reasons for dropping out throughout the
trial.</title>
                    <p>Abbreviations: ICBT, Internet-based cognitive behavior therapy; CBGT,
Cognitive behavioral group therapy; SAD, Social anxiety disorder;
Received, completed at least 5 modules (ICBT) or 5 sessions (CBGT).</p>
                  </caption>
                  <graphic xlink:href="pone.0018001.g001"/>
                </fig>
                <table-wrap id="pone-0018001-t001" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0018001.t001</object-id>
                  <label>Table 1</label>
                  <caption>
                    <title>Demographic description of the participants.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone-0018001-t001-1" xlink:href="pone.0018001.t001"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <td colspan="2" align="left" rowspan="1">Variable</td>
                          <td align="left" rowspan="1" colspan="1">ICBT</td>
                          <td align="left" rowspan="1" colspan="1">CBGT</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">n = 64</td>
                          <td align="left" rowspan="1" colspan="1">n = 62</td>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Gender</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">Women (%)</td>
                          <td align="left" rowspan="1" colspan="1">24.0 (37.5)</td>
                          <td align="left" rowspan="1" colspan="1">21.0 (33.8)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Men (%)</td>
                          <td align="left" rowspan="1" colspan="1">40.0 (62.5)</td>
                          <td align="left" rowspan="1" colspan="1">41.0 (66.1)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Age</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">Mean age (SD)</td>
                          <td align="left" rowspan="1" colspan="1">35.2 (11.1)</td>
                          <td align="left" rowspan="1" colspan="1">35.5 (11.6)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Min-max</td>
                          <td align="left" rowspan="1" colspan="1">20.1–63.2</td>
                          <td align="left" rowspan="1" colspan="1">18.0–64.1</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Social anxiety disorder</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">Generalized subtype (%)</td>
                          <td align="left" rowspan="1" colspan="1">56.0 (87.5)</td>
                          <td align="left" rowspan="1" colspan="1">53.0 (85.5)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Mean duration, years (median)</td>
                          <td align="left" rowspan="1" colspan="1">20 (18)</td>
                          <td align="left" rowspan="1" colspan="1">21.95 (21.5)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Mean age of onset</td>
                          <td align="left" rowspan="1" colspan="1">15.6</td>
                          <td align="left" rowspan="1" colspan="1">13.1</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Occupational status</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">Working 75–100 % (%)</td>
                          <td align="left" rowspan="1" colspan="1">51 (79.7)</td>
                          <td align="left" rowspan="1" colspan="1">42 (67.7)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Sick leave, part or full time (%)</td>
                          <td align="left" rowspan="1" colspan="1">4 (6.3)</td>
                          <td align="left" rowspan="1" colspan="1">6 (9.7)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Disability pension (%)</td>
                          <td align="left" rowspan="1" colspan="1">2 (3.2)</td>
                          <td align="left" rowspan="1" colspan="1">1 (1.6)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Referral</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">From out patient clinics</td>
                          <td align="left" rowspan="1" colspan="1">16 (25)</td>
                          <td align="left" rowspan="1" colspan="1">13 (21.0)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Self-referral</td>
                          <td align="left" rowspan="1" colspan="1">48 (75)</td>
                          <td align="left" rowspan="1" colspan="1">49 (79)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Stabilized psychotropic
medication</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">SSRIs</td>
                          <td align="left" rowspan="1" colspan="1">14</td>
                          <td align="left" rowspan="1" colspan="1">11</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">SNRIs</td>
                          <td align="left" rowspan="1" colspan="1">2</td>
                          <td align="left" rowspan="1" colspan="1">4</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Comorbid psychiatric disorders</td>
                          <td align="left" rowspan="1" colspan="1">Any anxiety disorder</td>
                          <td align="left" rowspan="1" colspan="1">10</td>
                          <td align="left" rowspan="1" colspan="1">12</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Major depression</td>
                          <td align="left" rowspan="1" colspan="1">10</td>
                          <td align="left" rowspan="1" colspan="1">9</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Avoidant personality disorder</td>
                          <td align="left" rowspan="1" colspan="1">33</td>
                          <td align="left" rowspan="1" colspan="1">29</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="nt101">
                      <label/>
                      <p>Abbreviations: ICBT, Internet-based Cognitive Behavior Therapy; CBGT,
Cognitive Behavior Group Therapy; SSRI, Selective serotonin reuptake
inhibitor; SNRI, Serotonin–norepinephrine reuptake
inhibitor.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="s2c">
                <title>Outcome measures</title>
                <sec id="s2c1">
                  <title>Social anxiety</title>
                  <p>The primary outcome measure was the clinician administrated Liebowitz Social
Anxiety Scale (LSAS) <xref rid="pone.0018001-Heimberg3" ref-type="bibr">[32]</xref>, <xref rid="pone.0018001-Liebowitz1" ref-type="bibr">[33]</xref>. The LSAS has good
psychometric properties including high internal consistency
(Cronbach’s <italic>α</italic> = .96) and
high test-retest reliability over one week
(<italic>r</italic> = .97) <xref rid="pone.0018001-Heimberg3" ref-type="bibr">[32]</xref>, <xref rid="pone.0018001-Soykan1" ref-type="bibr">[34]</xref>. The
self-report version of LSAS (LSAS-SR) <xref rid="pone.0018001-Baker1" ref-type="bibr">[35]</xref> was used as a complement
during the treatment phase The LSAS-SR has a high internal consistency
(Cronbach’s <italic>α</italic> = .95) as well
as a high 12-week test-retest reliability (<italic>r</italic>
 = .83) <xref rid="pone.0018001-Heimberg3" ref-type="bibr">[32]</xref>, <xref rid="pone.0018001-Baker1" ref-type="bibr">[35]</xref>. The
Social Phobia Scale (SPS) <xref rid="pone.0018001-Mattick1" ref-type="bibr">[36]</xref> and the Social Interaction Anxiety Scale (SIAS)
<xref rid="pone.0018001-Mattick1" ref-type="bibr">[36]</xref>
were also administered to assess a broader spectrum of social anxiety
symptoms. Both scales have good psychometric properties <xref rid="pone.0018001-Mattick1" ref-type="bibr">[36]</xref>.</p>
                </sec>
                <sec id="s2c2">
                  <title>General anxiety, anxiety sensitivity, depression and quality of
life</title>
                  <p>The Beck Anxiety Inventory (BAI) <xref rid="pone.0018001-Beck1" ref-type="bibr">[37]</xref> and the Anxiety
Sensitivity Index (ASI) <xref rid="pone.0018001-Reiss1" ref-type="bibr">[38]</xref> were used to assess general anxiety and anxiety
sensitivity. The Montgomery Åsberg Depression Rating Scale-self report
(MADRS-S) <xref rid="pone.0018001-Svanborg1" ref-type="bibr">[28]</xref> was used to measure depressive symptoms. Finally,
the Quality of Life Inventory (QOLI) <xref rid="pone.0018001-Frisch1" ref-type="bibr">[39]</xref> was used to assess
quality of life. The BAI, ASI, MADRS-S and the QOLI have all demonstrated
good psychometric properties.</p>
                </sec>
                <sec id="s2c3">
                  <title>Diagnostic assessment, global functioning and improvement</title>
                  <p>Psychiatric diagnoses were established using the SCID-I-Research version (RV)
<xref rid="pone.0018001-First1" ref-type="bibr">[26]</xref>,
the SCID-II <xref rid="pone.0018001-First2" ref-type="bibr">[40]</xref>, and the MINI <xref rid="pone.0018001-Sheehan1" ref-type="bibr">[27]</xref>. The SCID-I-RV was
used to assess SAD since it has the advantage of providing information in
greater detail than the MINI (which was not used to assess criteria for SAD)
and has high inter-rater reliability <xref rid="pone.0018001-Zanarini1" ref-type="bibr">[41]</xref>. To assess avoidant
personality disorder, we used SCID-II, which has very good inter-rater
reliability <xref rid="pone.0018001-Maffei1" ref-type="bibr">[42]</xref>. The MINI was used to assess axis I disorders
other than SAD <xref rid="pone.0018001-Sheehan1" ref-type="bibr">[27]</xref>. Assessors used the Global Assessment of
Functioning Scale (GAF) <xref rid="pone.0018001-American1" ref-type="bibr">[25]</xref> to measure global functioning and the Clinical
Global Impression Improvement Scale (CGI-I) <xref rid="pone.0018001-Guy1" ref-type="bibr">[43]</xref> to measure global
improvement.</p>
                </sec>
                <sec id="s2c4">
                  <title>Assessment of treatment credibility and treatment preference</title>
                  <p>A treatment credibility scale comprising five items was administered to
determine whether participants viewed the two treatments as equally credible
<xref rid="pone.0018001-Borkovec1" ref-type="bibr">[44]</xref>. Prior to randomization participants were asked to
state their treatment preference (ICBT or CBGT).</p>
                </sec>
              </sec>
              <sec id="s2d">
                <title>Administration format of self-report measures</title>
                <p>We used an Internet application to administer the LSAS-SR, SIAS, SPS, BAI,
MADRS-S, and the QOLI. Internet and paper-and-pencil administrations of these
measures have been shown to possess equivalent psychometric properties <xref rid="pone.0018001-Hedman1" ref-type="bibr">[45]</xref>.</p>
              </sec>
              <sec id="s2e">
                <title>Procedure</title>
                <sec id="s2e1">
                  <title>Assessment points and randomization</title>
                  <p>Assessments, including diagnostic interviews, were conducted before treatment
(i.e., pre-treatment), immediately after treatment (i.e., post-treatment),
and six months after treatment (i.e., follow-up). During treatment, the
LSAS-SR and the suicide ideation item of MADRS-S were administered on a
weekly basis. Participants assessed treatment credibility after one week of
treatment. The randomization procedure involved two external persons not
involved in the study; one provided randomization data and the other
monitored that no manipulation of treatment allocation was performed by the
research group. A true random number service (<ext-link ext-link-type="uri" xlink:href="http://www.random.org">http://www.random.org</ext-link>) was
used to ensure randomization. The random sequence was generated after
inclusion of participants to ensure that assignment of intervention was
concealed from assessing psychiatrists and researchers of the study.
Participants were allocated to CBGT or ICBT in a 1∶1 ratio using
simple randomization with no restrictions or matching. To ensure the
integrity of the blinding procedure, participants were instructed not to
mention which treatment they had received during the post-treatment and
follow-up interviews. After completing the interviews, the assessing
psychiatrists guessed allocation status for each participant.</p>
                </sec>
                <sec id="s2e2">
                  <title>Monitoring of treatment integrity</title>
                  <p>Treatment integrity of CBGT was ensured in three ways. First, we used a
detailed treatment manual <xref rid="pone.0018001-Heimberg4" ref-type="bibr">[46]</xref>. Second, group therapists received supervision
throughout the trial by a licensed psychotherapist specialized in CBT for
SAD. Third, all sessions were audio recorded and a random sample of 5
sessions was audited by a clinical psychologist with more than 10 years of
experience in treating SAD with CBT. Using the Therapist Adherence Scale
(TAS) developed by the originators of CBGT <xref rid="pone.0018001-Ledley1" ref-type="bibr">[47]</xref>, all reviewed sessions
were judged to have been conducted in accordance with the treatment manual.
The average TAS score of the reviewed session was 4.5
(SD = 0.5) on a 1 (ineffective) to 5 (extremely
effective) scale. Due to the fixed nature of ICBT and the limited role of
the therapist, no measure of treatment integrity was taken for ICBT.
However, all therapists who provided the guidance of ICBT received
supervision from a clinical psychologist throughout the trial and all
therapists had previous experience of that treatment format.</p>
                </sec>
              </sec>
              <sec id="s2f">
                <title>Treatments</title>
                <sec id="s2f1">
                  <title>Internet-based cognitive behavior therapy (ICBT)</title>
                  <p>The ICBT employed in this study was based on the treatment developed by
Andersson and coworkers, and has been validated by several randomized
controlled trials <xref rid="pone.0018001-Carlbring1" ref-type="bibr">[13]</xref>, <xref rid="pone.0018001-Andersson1" ref-type="bibr">[14]</xref>, <xref rid="pone.0018001-Tillfors1" ref-type="bibr">[15]</xref>. The
treatment followed a CBT-model, developed for individual therapy, that
stresses the importance of avoidance and safety behaviors as well as
misinterpretations of social events and internal focus as maintaining
factors of SAD <xref rid="pone.0018001-Clark2" ref-type="bibr">[48]</xref>. A vital part of the treatment was the gradual
access to internet-based self-help text comprising 15 text modules, each
covering a specific theme (e.g., exposure or cognitive restructuring)
completed with a homework component. The modules provided the participants
with the same knowledge and tools as conventional individual CBT for
SAD.</p>
                  <p>The duration of ICBT was 15 weeks and throughout this period the patient had
access to a therapist via an online secure messaging system. The role of the
therapist was mainly to provide feedback regarding home work and to grant
access to the treatment modules. However, the patient could contact the
therapist at any time and expect a reply within 24 hours during week days.
Patients and therapists had no face-to-face or telephone contact during the
treatment. The general instruction to the internet therapists was to have
the ambition to restrict time spent on each patient to less than 10 minutes
per week. This time frame was judged possible as most messages to patients
are very brief entailing the core feed-back that the homework was
successfully completed and the next treatment module is accessible. The
therapists conducting ICBT were eight psychologists with one to four years
of experience in delivering CBT via the internet.</p>
                </sec>
                <sec id="s2f2">
                  <title>Cognitive behavioral group therapy (CBGT)</title>
                  <p>This treatment comprised an initial individual session followed by 14 group
sessions over 15 weeks. The individual session prepared the participant to
begin group treatment sessions and included a rationale for group treatment.
Each group session was 2.5 hours long, including a 15 minute break. Groups
were lead by two therapists and had six to seven participants. The CBGT
followed the protocol developed by Heimberg and Becker <xref rid="pone.0018001-Heimberg4" ref-type="bibr">[46]</xref> with the addition of
two group sessions. The first two group sessions (i.e., Sessions 2–3)
were aimed at teaching participants the role and components of anxiety and
how to identify and challenge negative automatic thoughts. Sessions
4–14 focused primarily on individually tailored in-session exposure in
combination with cognitive restructuring. Prior to exposure exercises,
participants identified and disputed negative automatic thoughts, developed
rational alternatives, and behavioral goals were set. Following the exposure
exercises, additional cognitive restructuring was conducted and goal
attainment was reviewed. Participants were also given homework to continue
exposure exercises in the same fashion in their home environment. Session
14–15 were devoted to assessing the progress of the participant and
setting goals for the future. A detailed plan was created for each
participant to ensure that goals and methods to achieve them were clear. The
therapists facilitating the CBGT sessions were six clinical psychologists
with 2 to15 years experience in treating patients with SAD using CBT.</p>
                </sec>
              </sec>
              <sec id="s2g">
                <title>Statistical analysis</title>
                <p>Statistical analyses were conducted using PASW version 18.0 (SPSS inc., Chicago).
The non-inferiority margin of the primary outcome measure LSAS was set at
Δ10 points, which was based on clinical judgment and a review of the
evidence of CBGT compared to credible control conditions for SAD. Meta-analytic
reviews, adopting random-effects models, have estimated the lower bound of the
95% confidence interval (CI) of the between group effect size to 0.39
(Hedges’<italic>g</italic>) <xref rid="pone.0018001-Hofmann1" ref-type="bibr">[49]</xref>. Assuming a standard
variance of LSAS scores in our sample, this supported the use of 10 LSAS points
as a non-inferiority margin. Test criterion for non-inferiority was that the
lower bound of the 95% CI of the mean difference should fall within
Δ. With 95% probability, the mean difference between ICBT and CGBT
had to be smaller than 10 LSAS points. As this was a non-inferiority trial, this
criterion did not apply for the upper bound of the CI, meaning that the CI could
exceed 10 LSAS points if in favor of ICBT. For the other continuous measures,
the non-inferiority margin was set at Δ Cohen’s
<italic>d</italic> = 0.5. Test criterion for
non-inferiority for these measures was that the lower bound of the 95% CI
of between group effect sizes should fall within this range. This criterion was
judged acceptable as it has been proposed that an effect size of 0.5 marks the
border between a mild and moderate effect <xref rid="pone.0018001-ClarkCarter1" ref-type="bibr">[50]</xref>. Thus, this criterion
meant that mild effects up to the border of moderate effects were
acceptable.</p>
                <p>Main outcome continuous variables were analyzed using a linear mixed effects
model because of its superior qualities regarding missing data as well as in
reducing the risk of committing type I errors <xref rid="pone.0018001-Gueorguieva1" ref-type="bibr">[51]</xref>. We employed the
restricted maximum likelihood method assuming a compound symmetry model as
covariance structure since it provided the best model in an information criteria
comparison. T-tests were used to compare treatment credibility ratings and
χ<sup>2</sup> tests to assess nominal scale variables. Wilcoxon tests
and Mann-Whitney U tests were used to analyze outcomes on ordinal scale
variables. To estimate rates of responders, we used the clinical significant
improvement criteria as suggested by Jacobson and Truax on the primary outcome
measure <xref rid="pone.0018001-Jacobson1" ref-type="bibr">[52]</xref>. The criteria for clinical significant improvement was to
have a score below 43.3 (closer to healthy population than to SAD population
<xref rid="pone.0018001-Fresco1" ref-type="bibr">[53]</xref> and
the reliable change criterion was established using the test-retest reliability
coefficient of .97 <xref rid="pone.0018001-Soykan1" ref-type="bibr">[34]</xref>. Cohen’s <italic>d</italic> based on pooled
standard deviations was used to calculate effect sizes. The sample size was
considered satisfactory since power calculations showed that there was a chance
slightly lower than 80% to detect a difference, given the non-inferiority
criteria used and an alpha-level of .05. The main analyses were conducted in
accordance to intention-to-treat principle, i.e. all available assessment data
was analyzed in accordance to how participants were randomized. This meant that
participants were encouraged to provide assessment data regardless of treatment
adherence. On the CGI-I scale, missing values were replaced with “no
change”. As a complement, the social anxiety measures were also analyzed
based on the sample of completers only. There were no significant differences
between the groups on the outcome measures at baseline (<italic>t</italic>
<sub>(1, 124)</sub> = 0.02–1.38,
p = .17–.98).</p>
              </sec>
            </sec>
            <sec id="s3">
              <title>Results</title>
              <sec id="s3a">
                <title>Attrition</title>
                <p>Loss of data is presented in <xref ref-type="fig" rid="pone-0018001-g001">Figure
1</xref>.</p>
              </sec>
              <sec id="s3b">
                <title>Effect sizes and non-inferiority</title>
                <p>Within group effect sizes on the primary outcome measure LSAS were large for both
treatments. At post-treatment and six month follow-up respectively, the 95
% CI of the mean difference between the groups on LSAS score was
0.68–17.66 and −2.5–15.69, favoring ICBT. This was well within
the non-inferiority margin of 10 LSAS points for the lower bound. Analysis of
the other continuous measures showed that all lower bounds of 95% CIs for
between group effect sizes fell well within the non-inferiority margin of
<italic>d</italic> = 0.5 effect sizes. As stated above,
<xref ref-type="table" rid="pone-0018001-t002">Table 2</xref> provides
within and between group effect sizes on continuous outcome measures.</p>
                <table-wrap id="pone-0018001-t002" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0018001.t002</object-id>
                  <label>Table 2</label>
                  <caption>
                    <title>Means, SDs and effect sizes (Cohen’s <italic>d</italic>) for
measures of social anxiety and secondary outcome variables.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone-0018001-t002-2" xlink:href="pone.0018001.t002"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Effect size</td>
                          <td align="left" rowspan="1" colspan="1">Effect size</td>
                          <td align="left" rowspan="1" colspan="1">Effect size</td>
                          <td align="left" rowspan="1" colspan="1">Effect size</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Measure</td>
                          <td align="left" rowspan="1" colspan="1">Group</td>
                          <td align="left" rowspan="1" colspan="1">Pre</td>
                          <td align="left" rowspan="1" colspan="1">Post</td>
                          <td align="left" rowspan="1" colspan="1">FU</td>
                          <td align="left" rowspan="1" colspan="1">Between</td>
                          <td align="left" rowspan="1" colspan="1">Between</td>
                          <td align="left" rowspan="1" colspan="1">Whithin</td>
                          <td align="left" rowspan="1" colspan="1">Within</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">M (SD)</td>
                          <td align="left" rowspan="1" colspan="1">M (SD)</td>
                          <td align="left" rowspan="1" colspan="1">M (SD)</td>
                          <td align="left" rowspan="1" colspan="1">Post (95% CI)</td>
                          <td align="left" rowspan="1" colspan="1">Follow-up (95% CI)</td>
                          <td align="left" rowspan="1" colspan="1">Pre-Post</td>
                          <td align="left" rowspan="1" colspan="1">Pre-FU</td>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>LSAS</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">ICBT</td>
                          <td align="left" rowspan="1" colspan="1">68.4 (21.0)</td>
                          <td align="left" rowspan="1" colspan="1">39.4 (19.9)</td>
                          <td align="left" rowspan="1" colspan="1">32.1 (23.1)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">1.42</td>
                          <td align="left" rowspan="1" colspan="1">1.64</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">0.41 (0.03–0.78)</td>
                          <td align="left" rowspan="1" colspan="1">0.36 (−0.02–0.75)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">CBGT</td>
                          <td align="left" rowspan="1" colspan="1">71.9 (22.9)</td>
                          <td align="left" rowspan="1" colspan="1">48.5 (25.0)</td>
                          <td align="left" rowspan="1" colspan="1">40.7 (23.7)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">0.97</td>
                          <td align="left" rowspan="1" colspan="1">1.34</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>SIAS</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">ICBT</td>
                          <td align="left" rowspan="1" colspan="1">46.2 (16.8)</td>
                          <td align="left" rowspan="1" colspan="1">34.6 (15.1)</td>
                          <td align="left" rowspan="1" colspan="1">29.9 (15.7)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">0.73</td>
                          <td align="left" rowspan="1" colspan="1">1.01</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">0.24 (−0.11–0.59)</td>
                          <td align="left" rowspan="1" colspan="1">0.33 (−0.03–0.69)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">CBGT</td>
                          <td align="left" rowspan="1" colspan="1">49.3 (14.8)</td>
                          <td align="left" rowspan="1" colspan="1">38.53 (15.7)</td>
                          <td align="left" rowspan="1" colspan="1">34.6 (15.1)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">0.72</td>
                          <td align="left" rowspan="1" colspan="1">0.93</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>SPS</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">ICBT</td>
                          <td align="left" rowspan="1" colspan="1">32.8 (14.6)</td>
                          <td align="left" rowspan="1" colspan="1">21.6 (13.5)</td>
                          <td align="left" rowspan="1" colspan="1">17.6 (13.9)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">0.80</td>
                          <td align="left" rowspan="1" colspan="1">1.06</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">0.04 (−0.31–0.39)</td>
                          <td align="left" rowspan="1" colspan="1">0.16 (−0.20–0.51)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">CBGT</td>
                          <td align="left" rowspan="1" colspan="1">33.5 (14.0)</td>
                          <td align="left" rowspan="1" colspan="1">22.1 (14.3)</td>
                          <td align="left" rowspan="1" colspan="1">19.7 (13.6)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">0.80</td>
                          <td align="left" rowspan="1" colspan="1">0.99</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>MADRS-S</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">ICBT</td>
                          <td align="left" rowspan="1" colspan="1">12.7 (6.5)</td>
                          <td align="left" rowspan="1" colspan="1">9.1 (6.9)</td>
                          <td align="left" rowspan="1" colspan="1">8.8 (8.3)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">0.53</td>
                          <td align="left" rowspan="1" colspan="1">0.52</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">0.29 (−0.06–0.64)</td>
                          <td align="left" rowspan="1" colspan="1">0.21 (−0.15–0.57)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">CBGT</td>
                          <td align="left" rowspan="1" colspan="1">14.0 (8.0)</td>
                          <td align="left" rowspan="1" colspan="1">11.5 (8.8)</td>
                          <td align="left" rowspan="1" colspan="1">10.5 (8.6)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">0.30</td>
                          <td align="left" rowspan="1" colspan="1">0.41</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>BAI</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">ICBT</td>
                          <td align="left" rowspan="1" colspan="1">18.7 (10.9)</td>
                          <td align="left" rowspan="1" colspan="1">12.1 (8.6)</td>
                          <td align="left" rowspan="1" colspan="1">10.6 (10.0)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">0.67</td>
                          <td align="left" rowspan="1" colspan="1">0.77</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">0.21 (−0.14–0.56)</td>
                          <td align="left" rowspan="1" colspan="1">0.13 (−23–0.48)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">CBGT</td>
                          <td align="left" rowspan="1" colspan="1">18.6 (10.8)</td>
                          <td align="left" rowspan="1" colspan="1">14.2 (11.3)</td>
                          <td align="left" rowspan="1" colspan="1">11.8 (9.2)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">0.40</td>
                          <td align="left" rowspan="1" colspan="1">0.77</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>QOLI</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">ICBT</td>
                          <td align="left" rowspan="1" colspan="1">0.8 (1.5)</td>
                          <td align="left" rowspan="1" colspan="1">1.6 (1.6)</td>
                          <td align="left" rowspan="1" colspan="1">1.8 (1.5)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">0.51</td>
                          <td align="left" rowspan="1" colspan="1">0.69</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">0.27 (−0.08–0.62)</td>
                          <td align="left" rowspan="1" colspan="1">0.46 (0.10–0.82)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">CBGT</td>
                          <td align="left" rowspan="1" colspan="1">0.4 (1.6)</td>
                          <td align="left" rowspan="1" colspan="1">1.1 (1.7)</td>
                          <td align="left" rowspan="1" colspan="1">1.1 (1.5)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">0.45</td>
                          <td align="left" rowspan="1" colspan="1">0.47</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>ASI</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">ICBT</td>
                          <td align="left" rowspan="1" colspan="1">22.6 (11.0)</td>
                          <td align="left" rowspan="1" colspan="1">16.1 (10.8)</td>
                          <td align="left" rowspan="1" colspan="1">14.4 (11.3)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">0.59</td>
                          <td align="left" rowspan="1" colspan="1">0.73</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">0.14 (−0.21–0.49)</td>
                          <td align="left" rowspan="1" colspan="1">−0.11 (−0.44–0.27)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">CBGT</td>
                          <td align="left" rowspan="1" colspan="1">22.0 (10.0)</td>
                          <td align="left" rowspan="1" colspan="1">17.6 (10.7)</td>
                          <td align="left" rowspan="1" colspan="1">13.6 (8.7)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">0.42</td>
                          <td align="left" rowspan="1" colspan="1">0.89</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="nt102">
                      <label/>
                      <p>Abbreviations: ICBT, Internet-based Cognitive Behavior Therapy; CBGT,
Cognitive Behavior Group Therapy; Pre, before treatment; Post,
post-treatment; FU, six months after treatment; LSAS, Liebowitz
Social Anxiety Scale; SIAS, Social Interaction Scale; SPS, Social
Phobia Scale; MADRS-S, Montgomery-Åsberg Depression Rating
Scale-Self report; BAI, Beck Anxiety Inventory; QOLI, Quality of
Life Inventory; ASI, Anxiety Sensitivity Index.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="s3c">
                <title>Treatment effectiveness - primary outcome measure (LSAS)</title>
                <p>At post-treatment, 35 (55%) of the participants (95% CI,
42.5%–66.9%) in the ICBT group were classified as responders
according to the Jacobson and Truax criteria <xref rid="pone.0018001-Jacobson1" ref-type="bibr">[52]</xref> compared to 21
participants (34%) in the CBGT group (95% CI,
22.1%–45.7%). At six-month follow-up, the corresponding
number was 41 (64%) in the ICBT group (95% CI,
52.3%–75.8%) and 28 (45%) in the CBGT group
(95% CI, 32.8%–57.6%). Mixed effects model analysis
showed a significant effect of time, indicating improvement in both treatment
groups (<italic>F</italic> = 179.06;
df = 1,219; <italic>p</italic>&lt;.001). There was no
significant interaction of group and time for the primary outcome measure LSAS,
indicating similar improvement across groups
(<italic>F</italic> = 1.58; df = 2,
219; <italic>p</italic> = .21). As illustrated in <xref ref-type="fig" rid="pone-0018001-g002">Figure 2</xref>, there were
continuous within group improvements throughout the trial on the LSAS-SR in both
conditions. The means (SDs) on the LSAS-SR at pre, post and follow-up
respectively were 65.0 (23.6), 41.1 (21.5), 38.7 (23.1) for the ICBT group and
73.9 (21.5), 52.2 (25.5), 50.0 (24.9) for the CBGT group. There was no
significant interaction of group and time for the LSAS-SR
(<italic>F</italic> = 0.25; df = 2,
243; <italic>p</italic> = .77). <xref ref-type="table" rid="pone-0018001-t002">Table 2</xref> provides within and between group
effect sizes on measures of social anxiety, depression, general anxiety, quality
of life and anxiety sensitivity.</p>
                <fig id="pone-0018001-g002" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0018001.g002</object-id>
                  <label>Figure 2</label>
                  <caption>
                    <title>Weekly change on LSAS-SR during treatment and LSAS scores at each
assessment point.</title>
                    <p>Abbreviations: ICBT, Internet-based cognitive behavior therapy; CBGT,
Cognitive behavioral group therapy; LSAS, Liebowitz Social Anxiety
Scale; -SR, Self-report; CA, Clinician administered; Pre, Before
treatment; Post, Post-treatment; 6MFU, Six months after treatment.</p>
                  </caption>
                  <graphic xlink:href="pone.0018001.g002"/>
                </fig>
              </sec>
              <sec id="s3d">
                <title>Treatment effectiveness - secondary outcome measures</title>
                <sec id="s3d1">
                  <title>Social anxiety</title>
                  <p>There was a significant effect of time on both the SIAS and SPS
(<italic>F</italic> = 80.95 −83.39;
df = 2, <italic>p</italic>&lt;.001). Mixed effects
model analysis showed no significant interaction of group and time for these
variables (<italic>F</italic> = 0.30–0.48;
df = 2, 244;
<italic>p</italic> = .62–.74).</p>
                </sec>
                <sec id="s3d2">
                  <title>Depression, general anxiety, anxiety sensitivity and quality of
life</title>
                  <p>There was a significant effect of time on MADRS-S, BAI, ASI and QOLI
(<italic>F</italic> = 17.26–52.30;
df = 2, 227–245; <italic>p</italic>&lt;.001).
Analysis using mixed effects model yielded no significant interaction of
group and time for these variables
(<italic>F</italic> = 0.26–1.30;
df = 2, 227–245;
p = .28–.77).</p>
                </sec>
                <sec id="s3d3">
                  <title>Clinician administrated measures of global improvement and
functioning</title>
                  <p>At post-treatment, 42 participants (66%) in the ICBT group were
classified as very much improved or much improved according to the CGI-I
(95% CI, 59.1%–81.5%). In the CBGT group, the
corresponding number of participants was 34 (55%) as assessed using
the CGI-I (95% CI, 42.5%–67.2%). Wilcoxon tests
showed that participants who had received ICBT were further improved at
follow-up according to the CGI-I (Z = 2.33,
<italic>p</italic>&lt;.02), but CBGT participants were not
(Z = 1.50, p = .14). Mann-Whitney
U-test showed no significant difference between ICBT and CGBT at
post-treatment (<italic>p</italic> = .08.). However, at
six-month follow-up, participants receiving ICBT were significantly more
improved on the CGI-I (p&lt;.01). <xref ref-type="fig" rid="pone-0018001-g003">Figure 3</xref> displays CGI-I scores at
post-treatment and follow-up. The means (SDs) on the GAF at pre, post and
follow-up respectively were 57.3 (9.8), 66.8 (10.0), 70.4 (11.3) for the
CBGT group and 59.5 (6.4), 69.7 (10.8), 74.5 (11.6) for the ICBT group.
Using a mixed effects model approach, no significant interaction of time and
treatment group was found on the GAF
(<italic>F</italic> = 0.354;
df = 2, 225;
<italic>p</italic> = .59).</p>
                  <fig id="pone-0018001-g003" position="float">
                    <object-id pub-id-type="doi">10.1371/journal.pone.0018001.g003</object-id>
                    <label>Figure 3</label>
                    <caption>
                      <title>CGI-I scores at post-treatment and six-month follow-up.</title>
                      <p>Abbreviations: ICBT, Internet-based cognitive behavior therapy; CBGT,
Cognitive behavioral group therapy; CGI-I, Clinical Global
Impression Improvement Scale.</p>
                    </caption>
                    <graphic xlink:href="pone.0018001.g003"/>
                  </fig>
                </sec>
                <sec id="s3d4">
                  <title>Psychiatric diagnosis at each assessment point</title>
                  <p>Following treatment, 18 (31 %) participants who had received ICBT no
longer met diagnostic criteria for SAD (28 % if considering dropouts
as non-responders). The corresponding number for participants who underwent
CBGT was 12 (23 %; 19 % if considering dropouts
non-responders). At follow-up, 25 (46%) participants who had received
ICBT (41% if considering dropouts non-responders) and 21 (40%)
receiving CBGT (34% if considering dropouts non-responders) no longer
met diagnostic criteria for SAD. At post-treatment and six month follow-up
there was no significant difference in the prevalence of SAD between groups
(χ<sup>2</sup> = 037–1.33,
df = 1,
<italic>p</italic> = .25–.55).</p>
                </sec>
              </sec>
              <sec id="s3e">
                <title>Treatment credibility</title>
                <p>Credibility ratings after one week of treatment showed that participants in both
groups rated their respective treatment as credible. Out of a possible total of
50, the average scores were 34.0 (SD = 9.03) and 33.8
(SD = 10.6) for ICBT and CGBT, respectively. There was no
significant difference in treatment credibility between treatment groups
(<italic>t</italic>
<sub>(1, 110)</sub> = 0.07,
p = .95).</p>
              </sec>
              <sec id="s3f">
                <title>Assessment of blinding and treatment preference</title>
                <p>In four instances the blinding was broken. On two occasions participants
accidentally mentioned their treatment allocation status to the assessor, and in
other two occasions it was deemed necessary to break the blinding because of the
need to assess increased depressive symptoms during treatment. As shown in <xref ref-type="table" rid="pone-0018001-t003">Table 3</xref>, there was no
significant association between assessors’ guess and actual treatment
allocation (χ<sup>2</sup> = 0.27,
df = 1, <italic>p</italic> = .61),
indicating successful blinding.</p>
                <table-wrap id="pone-0018001-t003" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0018001.t003</object-id>
                  <label>Table 3</label>
                  <caption>
                    <title>Agreement between actual treatment status and assessors’ guess
(expected frequency).</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone-0018001-t003-3" xlink:href="pone.0018001.t003"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                        <col align="center" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Assignment</td>
                          <td align="left" rowspan="1" colspan="1">Assessors' guess</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">ICBT</td>
                          <td align="left" rowspan="1" colspan="1">CBGT</td>
                          <td align="left" rowspan="1" colspan="1">Total</td>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">ICBT</td>
                          <td align="left" rowspan="1" colspan="1">38 (36.6)</td>
                          <td align="left" rowspan="1" colspan="1">26 (27.4)</td>
                          <td align="left" rowspan="1" colspan="1">64</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">CBGT</td>
                          <td align="left" rowspan="1" colspan="1">34 (35.4)</td>
                          <td align="left" rowspan="1" colspan="1">28 (26.6)</td>
                          <td align="left" rowspan="1" colspan="1">62</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Total</td>
                          <td align="left" rowspan="1" colspan="1">72</td>
                          <td align="left" rowspan="1" colspan="1">54</td>
                          <td align="left" rowspan="1" colspan="1">126</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="nt103">
                      <label/>
                      <p>Abbreviations: ICBT, Internet-based Cognitive Behavior Therapy; CBGT,
Cognitive Behavior Group Therapy.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>Prior to randomization participants were asked to state their treatment
preference. Of 126 participants, 68 (54%) preferred ICBT and 58
(46%) CBGT. There was no difference between groups in terms of proportion
of participants that received the preferred treatment
(χ<sup>2</sup> = 0.77, df = 1,
<italic>p</italic> = .38).</p>
              </sec>
              <sec id="s3g">
                <title>Treatment adherence</title>
                <p>In CBGT, the average number of attended sessions per participant was 9.40
(SD = 4.87) out of a possible total of 15. Fifty
participants in CBGT (81%) attended at least five sessions and 17
(27%) attended all sessions. The average number of completed modules in
ICBT was 9.33 (SD = 4.95) of 15. Fifty-one participants in
ICBT (80%) completed at least 5 modules and 19 (29.7%) completed
all modules. Important to note is that the main components of the treatments had
been introduced at week 5.</p>
              </sec>
              <sec id="s3h">
                <title>Evaluation of therapist resources required for each treatment</title>
                <p>On average, therapists delivering ICBT spent 5.5 minutes
(SD = 3.6) weekly per patient. The corresponding amount of
time in CBGT was 50 minutes (2.5 h sessions with two therapists and 6 patients).
Taking nonattendance into consideration, this number would have been even
higher. ICBT therapists sent 17.4 messages to each patient on average, i.e. 1.2
weekly per patient.</p>
              </sec>
              <sec id="s3i">
                <title>Intention-to-treat vs. treatment exposed analysis</title>
                <p>Analysis including only those exposed to treatment (at least five sessions or
modules) yielded results equal to the intention-to-treat analysis on continuous
outcome measures of social anxiety, indicating that between group effects in the
latter were not moderated by completion status. There was a significant effect
of time on all three measures (<italic>F</italic> = 90.52
-188.67; df = 2, 188–198;
<italic>p</italic>&lt;.001). Mixed effects models analysis showed no significant
interaction effect of time and treatment group on the LSAS
(<italic>F</italic> = 1.78; df = 2,
188; <italic>p</italic> = .17), nor on the SIAS and the SPS
(<italic>F</italic> = 0.32–0.43;
df = 2, 198;
<italic>p</italic> = .66–.73).</p>
              </sec>
            </sec>
            <sec id="s4">
              <title>Discussion</title>
              <p>The present study is the first to demonstrate that ICBT can be as effective as CBGT
in the treatment of SAD. Both treatments demonstrated large within group effect
sizes on measures of social anxiety and general anxiety. The confidence interval of
mean differences of the primary outcome measure fell well within the non-inferiority
margin and between-group effect sizes were small but consistently favoring ICBT on
the social anxiety measures. There was also a large proportion of participants who
were classified as much improved or very much improved at post-treatment and
follow-up in both treatment groups. The indication that the ICBT group was slightly
more improved on the CGI-I should be interpreted cautiously as effects were small
and no alpha-level corrections were set. The follow-up assessment indicated that
treatment gains were sustained on all measures. These results indicate that ICBT can
be an effective treatment for patients with SAD when delivered in a regular
psychiatric setting.</p>
              <p>In trials assessing non-inferiority it is essential that the effect of the gold
standard treatment is as effective as in previous trials. This was the case in the
present study, where CBGT yielded effects in line with trials conducted by its
originators <xref rid="pone.0018001-Heimberg5" ref-type="bibr">[54]</xref>. Moreover, treatment effects for ICBT were equivalent to
those reported in previous controlled trials <xref rid="pone.0018001-Carlbring1" ref-type="bibr">[13]</xref>, <xref rid="pone.0018001-Andersson1" ref-type="bibr">[14]</xref>, <xref rid="pone.0018001-Tillfors1" ref-type="bibr">[15]</xref>, <xref rid="pone.0018001-Berger1" ref-type="bibr">[17]</xref>, <xref rid="pone.0018001-Titov1" ref-type="bibr">[18]</xref>. These are strengths of the
present study. As reduced therapist time is an important element of ICBT, a key
finding in this study is that ICBT reduced therapist time per treated patient by
90% compared to CBGT. As previously stated, individual CBT developed by Clark
and Wells (1995) may be even more effective than CBGT. It could therefore be argued
that Clark’s individual cognitive therapy should be the benchmark against
which ICBT is contrasted. However, as CBGT has been evaluated in more trials and is
more established, we decided to use CBGT as the benchmark treatment.</p>
              <p>Overall, we interpret the results of the present study as indicating that a
substantial proportion of persons with SAD respond well to ICBT. However, for those
who do not respond to ICBT, an intensified treatment such as individual face-to-face
CBT might be superior. Thus, we view ICBT as a complement (not a substitute) to
conventional CBT that could facilitate the dissemination of CBT and improve
healthcare resource allocation. When results are interpreted it is also important to
bear in mind that that the non-inferiority margin allowed for up to a moderate
effect between treatments. However, this margin was judged as clinically valid, and
again, if ICBT is to be used as a complement, the usefulness of employing very
narrow non-inferiority margins is limited.</p>
              <p>There are several limitations that warrant mention and could provide venues for
future research. First, there was no randomization to an active placebo condition,
which raises the issue of misinterpreting regression to the mean as indicative of
two effective treatments. However, given the chronicity demonstrated by SAD <xref rid="pone.0018001-Yonkers1" ref-type="bibr">[55]</xref>, high
proportions of spontaneous remission is improbable. In addition, meta-analytic
evidence suggests CBT for anxiety disorders tends to be more effective than placebo
<xref rid="pone.0018001-Hofmann1" ref-type="bibr">[49]</xref>. A
second limitation concerns patient preferences. It is likely that participants in
our trial were willing to receive either ICBT or CBGT, which may not be
representative for persons with SAD in the general population. It may be that
internet treatment is preferred over group treatment. Despite the observation that
persons with SAD are frequent internet users <xref rid="pone.0018001-Erwin1" ref-type="bibr">[56]</xref>, this has not yet been studied.
Third, the current study did not include long-term follow-up and, as such, it cannot
be determined if the effects of the CBGT and ICBTs protocol for SAD are enduring
over durations longer than six months. However, previous studies of CBGT <xref rid="pone.0018001-Heimberg6" ref-type="bibr">[57]</xref> and ICBT
suggest that the results may be enduring <xref rid="pone.0018001-Carlbring2" ref-type="bibr">[19]</xref>. The adherence rate also
deserves mentioning. Eighty percent of the participants completed at least the first
five weeks of therapy and were thereby exposed to the main components of the
treatment, although significantly fewer completed all sessions or modules. Still, we
find that having completed five weeks is an important threshold as preliminary
analyses of outcome predictors have shown that completing at least five weeks is
associated with better outcome, whereas completing all sessions or modules seems to
yield little additional effect. As for CBGT, this adherence rate is comparable to
that of a recently conducted large scale RCT where 35% of CBGT participants
discontinued treatment <xref rid="pone.0018001-Blanco1" ref-type="bibr">[58]</xref>. Finally, we did not assess treatment satisfaction in the
present study. However, data from regular care of the Internet clinic where this
study was conducted suggest high satisfaction with treatment as the average score on
the Client Satisfaction Questionnaire <xref rid="pone.0018001-Attkisson1" ref-type="bibr">[59]</xref> is 3.18
(SD = 0.57) using a scale range of 1–4.</p>
              <p>In spite of these limitations, we conclude that ICBT may be at least as effective as
CBGT, and that it is feasible to conduct ICBT for SAD in a psychiatric setting. As
ICBT requires much less resources than conventional CBT, it could be the most
promising means to increase the availability of CBT for persons affected by SAD.</p>
            </sec>
            <sec sec-type="supplementary-material" id="s5">
              <title>Supporting Information</title>
              <supplementary-material content-type="local-data" id="pone.0018001.s001">
                <label>Protocol S1</label>
                <caption>
                  <p>
                    <bold>Trial Protocol.</bold>
                  </p>
                  <p>(DOC)</p>
                </caption>
                <media xlink:href="pone.0018001.s001.doc">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0018001.s002">
                <label>Checklist S1</label>
                <caption>
                  <p>
                    <bold>CONSORT Checklist.</bold>
                  </p>
                  <p>(DOC)</p>
                </caption>
                <media xlink:href="pone.0018001.s002.doc">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack>
              <p><bold>Additional contributions:</bold> We wish to express our great appreciation of
the important work done by the following persons; Monica Hellberg (BA) for providing
aid in collecting the data; Anna-Clara Hellstadius for reviewing group sessions;
Sara Rydh (MS), Kerstin Blom (MS) and Jan Bergström (PhD) for conducting group
therapy; Gordon Asmundson (PhD) and Mathew Fetzner (BA) for giving comments on the
manuscript; Karin Hyland (MD), Carl Granfors (MD), Anne-Christine Fredman (MD),
Sergej Andréewitch (MD) and Diana Radu (MD, PhD) for psychiatric
assessments.</p>
            </ack>
            <fn-group>
              <fn fn-type="COI-statement">
                <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
              </fn>
              <fn fn-type="financial-disclosure">
                <p><bold>Funding: </bold>This study was supported by research grants from Stockholm County Council (Nils
Lindefors) and the Bror Gadelius Fund (Erik Hedman). The main funding
organization (Stockholm County Council) is a public institution and neither of
the funding organizations had any role in the design and conduct of the study;
in the collection, management, and analysis of the data; or in the preparation,
review and approval of the manuscript.</p>
              </fn>
            </fn-group>
            <ref-list>
              <title>References</title>
              <ref id="pone.0018001-Kessler1">
                <label>1</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kessler</surname>
                      <given-names>RC</given-names>
                    </name>
                    <name>
                      <surname>Berglund</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Demler</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Jin</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Merikangas</surname>
                      <given-names>KR</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2005</year>
                  <article-title>Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV
Disorders in the National Comorbidity Survey Replication.</article-title>
                  <source>Arch Gen Psychiatry</source>
                  <volume>62</volume>
                  <fpage>593</fpage>
                  <lpage>602</lpage>
                  <pub-id pub-id-type="pmid">15939837</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Reich1">
                <label>2</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Reich</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Goldenberg</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Vasile</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Goisman</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Keller</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <year>1994</year>
                  <article-title>A prospective follow-along study of the course of social
phobia.</article-title>
                  <source>Psychiatry Res</source>
                  <volume>54</volume>
                  <fpage>249</fpage>
                  <lpage>258</lpage>
                  <pub-id pub-id-type="pmid">7792329</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Ruscio1">
                <label>3</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ruscio</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Brown</surname>
                      <given-names>TA</given-names>
                    </name>
                    <name>
                      <surname>Chiu</surname>
                      <given-names>WT</given-names>
                    </name>
                    <name>
                      <surname>Sareen</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Stein</surname>
                      <given-names>MB</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2008</year>
                  <article-title>Social fears and social phobia in the USA: results from the
National Comorbidity Survey Replication.</article-title>
                  <source>Psychol Med</source>
                  <volume>38</volume>
                  <fpage>15</fpage>
                  <lpage>28</lpage>
                  <pub-id pub-id-type="pmid">17976249</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Schneier1">
                <label>4</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schneier</surname>
                      <given-names>FR</given-names>
                    </name>
                    <name>
                      <surname>Heckelman</surname>
                      <given-names>LR</given-names>
                    </name>
                    <name>
                      <surname>Garfinkel</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Campeas</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Fallon</surname>
                      <given-names>BA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>1994</year>
                  <article-title>Functional impairment in social phobia.</article-title>
                  <source>J Clin Psychiatry</source>
                  <volume>55</volume>
                  <fpage>322</fpage>
                  <lpage>331</lpage>
                  <pub-id pub-id-type="pmid">8071299</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Heimberg1">
                <label>5</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Heimberg</surname>
                      <given-names>RG</given-names>
                    </name>
                    <name>
                      <surname>Dodge</surname>
                      <given-names>CS</given-names>
                    </name>
                    <name>
                      <surname>Hope</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Kennedy</surname>
                      <given-names>CR</given-names>
                    </name>
                    <name>
                      <surname>Zollo</surname>
                      <given-names>LJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>1990</year>
                  <article-title>Cognitive behavioral group treatment for social phobia:
Comparison with a credible placebo control.</article-title>
                  <source>Cognitive Ther Res</source>
                  <volume>14</volume>
                  <fpage>1</fpage>
                  <lpage>23</lpage>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Heimberg2">
                <label>6</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Heimberg</surname>
                      <given-names>RG</given-names>
                    </name>
                  </person-group>
                  <year>2002</year>
                  <article-title>Cognitive-behavioral therapy for social anxiety disorder: current
status and future directions.</article-title>
                  <source>Biol Psychiatry</source>
                  <volume>51</volume>
                  <fpage>101</fpage>
                  <lpage>108</lpage>
                  <pub-id pub-id-type="pmid">11801235</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-JorstadStein1">
                <label>7</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jorstad-Stein</surname>
                      <given-names>EC</given-names>
                    </name>
                    <name>
                      <surname>Heimberg</surname>
                      <given-names>RG</given-names>
                    </name>
                  </person-group>
                  <year>2009</year>
                  <article-title>Social phobia: an update on treatment.</article-title>
                  <source>Psychiatr Clin North Am</source>
                  <volume>32</volume>
                  <fpage>641</fpage>
                  <lpage>663</lpage>
                  <pub-id pub-id-type="pmid">19716995</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Ponniah1">
                <label>8</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ponniah</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Hollon</surname>
                      <given-names>SD</given-names>
                    </name>
                  </person-group>
                  <year>2008</year>
                  <article-title>Empirically supported psychological interventions for social
phobia in adults: a qualitative review of randomized controlled
trials.</article-title>
                  <source>Psychol Med</source>
                  <volume>38</volume>
                  <fpage>3</fpage>
                  <lpage>14</lpage>
                  <pub-id pub-id-type="pmid">17640438</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Shapiro1">
                <label>9</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shapiro</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Cavanagh</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Lomas</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <year>2003</year>
                  <article-title>Geographic inequity in the availability of cognitive behavioural
therapy in England and Wales.</article-title>
                  <source>Behav Cogn Psychother</source>
                  <volume>31</volume>
                  <fpage>185</fpage>
                  <lpage>192</lpage>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Clark1">
                <label>10</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Clark</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>Ehlers</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>McManus</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Hackmann</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Fennell</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2003</year>
                  <article-title>Cognitive therapy versus fluoxetine in generalized social phobia:
a randomized placebo-controlled trial.</article-title>
                  <source>J Consult Clin Psychol</source>
                  <volume>71</volume>
                  <fpage>1058</fpage>
                  <lpage>1067</lpage>
                  <pub-id pub-id-type="pmid">14622081</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Stangier1">
                <label>11</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stangier</surname>
                      <given-names>U</given-names>
                    </name>
                    <name>
                      <surname>Heidenreich</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Peitz</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Lauterbach</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Clark</surname>
                      <given-names>DM</given-names>
                    </name>
                  </person-group>
                  <year>2003</year>
                  <article-title>Cognitive therapy for social phobia: individual versus group
treatment.</article-title>
                  <source>Behav Res Ther</source>
                  <volume>41</volume>
                  <fpage>991</fpage>
                  <lpage>1007</lpage>
                  <pub-id pub-id-type="pmid">12914803</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Mrtberg1">
                <label>12</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mörtberg</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Clark</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>Sundin</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Aberg Wistedt</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <year>2007</year>
                  <article-title>Intensive group cognitive treatment and individual cognitive
therapy versus treatment as usual in social phobia: a randomized controlled
trial.</article-title>
                  <source>Acta Psychiatr Scand</source>
                  <volume>115</volume>
                  <fpage>142</fpage>
                  <lpage>154</lpage>
                  <pub-id pub-id-type="pmid">17244178</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Carlbring1">
                <label>13</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Carlbring</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Gunnarsdottir</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Hedensjo</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Andersson</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Ekselius</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2007</year>
                  <article-title>Treatment of social phobia: randomised trial of
internet-delivered cognitive-behavioural therapy with telephone
support.</article-title>
                  <source>Br J Psychiatry</source>
                  <volume>190</volume>
                  <fpage>123</fpage>
                  <lpage>128</lpage>
                  <pub-id pub-id-type="pmid">17267928</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Andersson1">
                <label>14</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Andersson</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Carlbring</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Holmstrom</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Sparthan</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Furmark</surname>
                      <given-names>T</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2006</year>
                  <article-title>Internet-based self-help with therapist feedback and in vivo
group exposure for social phobia: a randomized controlled
trial.</article-title>
                  <source>J Consult Clin Psychol</source>
                  <volume>74</volume>
                  <fpage>677</fpage>
                  <lpage>686</lpage>
                  <pub-id pub-id-type="pmid">16881775</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Tillfors1">
                <label>15</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tillfors</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Carlbring</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Furmark</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Lewenhaupt</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Spak</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2008</year>
                  <article-title>Treating university students with social phobia and public
speaking fears: Internet delivered self-help with or without live group
exposure sessions.</article-title>
                  <source>Depress Anxiety</source>
                  <volume>25</volume>
                  <fpage>708</fpage>
                  <lpage>717</lpage>
                  <pub-id pub-id-type="pmid">18729147</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Furmark1">
                <label>16</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Furmark</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Carlbring</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Hedman</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Sonnenstein</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Clevberger</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2009</year>
                  <article-title>Guided and unguided self-help for social anxiety disorder:
randomised controlled trial.</article-title>
                  <source>Br J Psychiatry</source>
                  <volume>195</volume>
                  <fpage>440</fpage>
                  <lpage>447</lpage>
                  <pub-id pub-id-type="pmid">19880935</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Berger1">
                <label>17</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Berger</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Hohl</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Caspar</surname>
                      <given-names>F</given-names>
                    </name>
                  </person-group>
                  <year>2009</year>
                  <article-title>Internet-based treatment for social phobia: a randomized
controlled trial.</article-title>
                  <source>J Clin Psychol</source>
                  <volume>65</volume>
                  <fpage>1021</fpage>
                  <lpage>1035</lpage>
                  <pub-id pub-id-type="pmid">19437505</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Titov1">
                <label>18</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Titov</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Andrews</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Schwencke</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Drobny</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Einstein</surname>
                      <given-names>D</given-names>
                    </name>
                  </person-group>
                  <year>2008</year>
                  <article-title>Shyness 1: distance treatment of social phobia over the
Internet.</article-title>
                  <source>Aust N Z J Psychiatry</source>
                  <volume>42</volume>
                  <fpage>585</fpage>
                  <lpage>594</lpage>
                  <pub-id pub-id-type="pmid">18612862</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Carlbring2">
                <label>19</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Carlbring</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Nordgren</surname>
                      <given-names>LB</given-names>
                    </name>
                    <name>
                      <surname>Furmark</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Andersson</surname>
                      <given-names>G</given-names>
                    </name>
                  </person-group>
                  <year>2009</year>
                  <article-title>Long-term outcome of Internet-delivered cognitive-behavioural
therapy for social phobia: a 30-month follow-up.</article-title>
                  <source>Behav Res Ther</source>
                  <volume>47</volume>
                  <fpage>848</fpage>
                  <lpage>850</lpage>
                  <pub-id pub-id-type="pmid">19631312</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Andersson2">
                <label>20</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Andersson</surname>
                      <given-names>G</given-names>
                    </name>
                  </person-group>
                  <year>2009</year>
                  <article-title>Using the Internet to provide cognitive behaviour
therapy.</article-title>
                  <source>Behav Res Ther</source>
                  <volume>47</volume>
                  <fpage>175</fpage>
                  <lpage>180</lpage>
                  <pub-id pub-id-type="pmid">19230862</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Barak1">
                <label>21</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Barak</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Klein</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Proudfoot</surname>
                      <given-names>JG</given-names>
                    </name>
                  </person-group>
                  <year>2009</year>
                  <article-title>Defining internet-supported therapeutic
interventions.</article-title>
                  <source>Ann Behav Med</source>
                  <volume>38</volume>
                  <fpage>4</fpage>
                  <lpage>17</lpage>
                  <pub-id pub-id-type="pmid">19787305</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Titov2">
                <label>22</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Titov</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Andrews</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Kemp</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Robinson</surname>
                      <given-names>E</given-names>
                    </name>
                  </person-group>
                  <year>2010</year>
                  <article-title>Characteristics of adults with anxiety or depression treated at
an internet clinic: comparison with a national survey and an outpatient
clinic.</article-title>
                  <source>PLoS ONE</source>
                  <volume>5</volume>
                  <fpage>e10885</fpage>
                  <pub-id pub-id-type="pmid">20526371</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Hunsley1">
                <label>23</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hunsley</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>CM</given-names>
                    </name>
                  </person-group>
                  <year>2007</year>
                  <article-title>Research-Informed Benchmarks for Psychological Treatments:
Efficacy Studies, Effectiveness Studies, and Beyond.</article-title>
                  <source>Prof Psychol-Res Pr</source>
                  <volume>38</volume>
                  <fpage>21</fpage>
                  <lpage>33</lpage>
                </element-citation>
              </ref>
              <ref id="pone.0018001-McAlister1">
                <label>24</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McAlister</surname>
                      <given-names>FA</given-names>
                    </name>
                    <name>
                      <surname>Sackett</surname>
                      <given-names>DL</given-names>
                    </name>
                  </person-group>
                  <year>2001</year>
                  <article-title>Active-control equivalence trials and antihypertensive
agents.</article-title>
                  <source>Am J Med</source>
                  <volume>111</volume>
                  <fpage>553</fpage>
                  <lpage>558</lpage>
                  <pub-id pub-id-type="pmid">11705432</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-American1">
                <label>25</label>
                <element-citation publication-type="book">
                  <year>2000</year>
                  <source>Diagnostic and statistical manual of mental disorders: DSM-IV-TR.</source>
                  <publisher-loc>Washington, DC</publisher-loc>
                  <publisher-name>American Psychiatric Association</publisher-name>
                  <fpage>xxxvii</fpage>
                  <size units="page">943</size>
                </element-citation>
              </ref>
              <ref id="pone.0018001-First1">
                <label>26</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="editor">
                    <name>
                      <surname>First</surname>
                      <given-names>MB</given-names>
                    </name>
                    <name>
                      <surname>Spitzer</surname>
                      <given-names>RL</given-names>
                    </name>
                    <name>
                      <surname>Gibbon</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Williams</surname>
                      <given-names>JBW</given-names>
                    </name>
                  </person-group>
                  <year>2002</year>
                  <article-title>Structured clinical interview for DSM-IV-TR axis I Disorders,
research version, patient edition.</article-title>
                  <publisher-loc>New York</publisher-loc>
                  <publisher-name>Biometrics Research, New York State Psychiatric
Institute</publisher-name>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Sheehan1">
                <label>27</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sheehan</surname>
                      <given-names>DV</given-names>
                    </name>
                    <name>
                      <surname>Lecrubier</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Sheehan</surname>
                      <given-names>KH</given-names>
                    </name>
                    <name>
                      <surname>Amorim</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Janavs</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>1998</year>
                  <article-title>The Mini-International Neuropsychiatric Interview (M.I.N.I.): the
development and validation of a structured diagnostic psychiatric interview
for DSM-IV and ICD-10.</article-title>
                  <source>J Clin Psychiatry</source>
                  <volume>59</volume>
                  <issue>Suppl 20</issue>
                  <fpage>22</fpage>
                  <lpage>33</lpage>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Svanborg1">
                <label>28</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Svanborg</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Åsberg</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <year>1994</year>
                  <article-title>A new self-rating scale for depression and anxiety states based
on the Comprehensive Psychopathological Rating Scale.</article-title>
                  <source>Acta Psychiatr Scand</source>
                  <volume>89</volume>
                  <fpage>21</fpage>
                  <lpage>28</lpage>
                  <pub-id pub-id-type="pmid">8140903</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Furmark2">
                <label>29</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Furmark</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Tillfors</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Everz</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Marteinsdottir</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Gefvert</surname>
                      <given-names>O</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>1999</year>
                  <article-title>Social phobia in the general population: prevalence and
sociodemographic profile.</article-title>
                  <source>Soc Psychiatry Psychiatr Epidemiol</source>
                  <volume>34</volume>
                  <fpage>416</fpage>
                  <lpage>424</lpage>
                  <pub-id pub-id-type="pmid">10501711</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Saunders1">
                <label>30</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Saunders</surname>
                      <given-names>JB</given-names>
                    </name>
                    <name>
                      <surname>Aasland</surname>
                      <given-names>OG</given-names>
                    </name>
                    <name>
                      <surname>Babor</surname>
                      <given-names>TF</given-names>
                    </name>
                    <name>
                      <surname>de la Fuente</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Grant</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <year>1993</year>
                  <article-title>Development of the Alcohol Use Disorders Identification Test
(AUDIT): WHO Collaborative Project on Early Detection of Persons with
Harmful Alcohol Consumption.</article-title>
                  <source>Addiction</source>
                  <volume>88</volume>
                  <fpage>791</fpage>
                  <lpage>804</lpage>
                  <pub-id pub-id-type="pmid">8329970</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Berman1">
                <label>31</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Berman</surname>
                      <given-names>AH</given-names>
                    </name>
                    <name>
                      <surname>Bergman</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Palmstierna</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Schlyter</surname>
                      <given-names>F</given-names>
                    </name>
                  </person-group>
                  <year>2005</year>
                  <article-title>Evaluation of the Drug Use Disorders Identification Test (DUDIT)
in criminal justice and detoxification settings and in a Swedish population
sample.</article-title>
                  <source>Eur Addict Res</source>
                  <volume>11</volume>
                  <fpage>22</fpage>
                  <lpage>31</lpage>
                  <pub-id pub-id-type="pmid">15608468</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Heimberg3">
                <label>32</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Heimberg</surname>
                      <given-names>RG</given-names>
                    </name>
                    <name>
                      <surname>Horner</surname>
                      <given-names>KJ</given-names>
                    </name>
                    <name>
                      <surname>Juster</surname>
                      <given-names>HR</given-names>
                    </name>
                    <name>
                      <surname>Safren</surname>
                      <given-names>SA</given-names>
                    </name>
                    <name>
                      <surname>Brown</surname>
                      <given-names>EJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>1999</year>
                  <article-title>Psychometric properties of the Liebowitz Social Anxiety
Scale.</article-title>
                  <source>Psychol Med</source>
                  <volume>29</volume>
                  <fpage>199</fpage>
                  <lpage>212</lpage>
                  <pub-id pub-id-type="pmid">10077308</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Liebowitz1">
                <label>33</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Liebowitz</surname>
                      <given-names>MR</given-names>
                    </name>
                  </person-group>
                  <year>1987</year>
                  <article-title>Social phobia.</article-title>
                  <source>Mod Probl Pharmacopsychiatry</source>
                  <volume>22</volume>
                  <fpage>141</fpage>
                  <lpage>173</lpage>
                  <pub-id pub-id-type="pmid">2885745</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Soykan1">
                <label>34</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Soykan</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Ozguven</surname>
                      <given-names>HD</given-names>
                    </name>
                    <name>
                      <surname>Gencoz</surname>
                      <given-names>T</given-names>
                    </name>
                  </person-group>
                  <year>2003</year>
                  <article-title>Liebowitz Social Anxiety Scale: the Turkish
version.</article-title>
                  <source>Psychol Rep</source>
                  <volume>93</volume>
                  <fpage>1059</fpage>
                  <lpage>1069</lpage>
                  <pub-id pub-id-type="pmid">14765570</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Baker1">
                <label>35</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Baker</surname>
                      <given-names>SL</given-names>
                    </name>
                    <name>
                      <surname>Heinrichs</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>H-J</given-names>
                    </name>
                    <name>
                      <surname>Hofmann</surname>
                      <given-names>SG</given-names>
                    </name>
                  </person-group>
                  <year>2002</year>
                  <article-title>The Liebowitz Social Anxiety Scale as a self-report instrument: a
preliminary psychometric analysis.</article-title>
                  <source>Behav Res Ther</source>
                  <volume>40</volume>
                  <fpage>701</fpage>
                  <lpage>715</lpage>
                  <pub-id pub-id-type="pmid">12051488</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Mattick1">
                <label>36</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mattick</surname>
                      <given-names>RP</given-names>
                    </name>
                    <name>
                      <surname>Clarke</surname>
                      <given-names>JC</given-names>
                    </name>
                  </person-group>
                  <year>1998</year>
                  <article-title>Development and validation of measures of social phobia scrutiny
fear and social interaction anxiety.</article-title>
                  <source>Behav Res Ther</source>
                  <volume>36</volume>
                  <fpage>455</fpage>
                  <lpage>470</lpage>
                  <pub-id pub-id-type="pmid">9670605</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Beck1">
                <label>37</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Beck</surname>
                      <given-names>AT</given-names>
                    </name>
                    <name>
                      <surname>Epstein</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Brown</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Steer</surname>
                      <given-names>RA</given-names>
                    </name>
                  </person-group>
                  <year>1988</year>
                  <article-title>An inventory for measuring clinical anxiety: psychometric
properties.</article-title>
                  <source>J Consult Clin Psychol</source>
                  <volume>56</volume>
                  <fpage>893</fpage>
                  <lpage>897</lpage>
                  <pub-id pub-id-type="pmid">3204199</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Reiss1">
                <label>38</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Reiss</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Peterson</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Gursky</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>McNally</surname>
                      <given-names>RJ</given-names>
                    </name>
                  </person-group>
                  <year>1986</year>
                  <article-title>Anxiety sensitivity, anxiety frequency and the prediction of
fearfulness.</article-title>
                  <source>Behav Res Ther</source>
                  <volume>24</volume>
                  <fpage>1</fpage>
                  <lpage>8</lpage>
                  <pub-id pub-id-type="pmid">3947307</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Frisch1">
                <label>39</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Frisch</surname>
                      <given-names>MB</given-names>
                    </name>
                    <name>
                      <surname>Cornell</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Villanueva</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Retzlaff</surname>
                      <given-names>PJ</given-names>
                    </name>
                  </person-group>
                  <year>1992</year>
                  <article-title>Clinical validation of the Quality of Life Inventory. A measure
of life satisfaction for use in treatment planning and outcome
assessment.</article-title>
                  <source>Psychol Assess</source>
                  <volume>4</volume>
                  <fpage>92</fpage>
                  <lpage>101</lpage>
                </element-citation>
              </ref>
              <ref id="pone.0018001-First2">
                <label>40</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>First</surname>
                      <given-names>MB</given-names>
                    </name>
                    <name>
                      <surname>Gibbon</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Spitzer</surname>
                      <given-names>RL</given-names>
                    </name>
                    <name>
                      <surname>Williams</surname>
                      <given-names>JBW</given-names>
                    </name>
                    <name>
                      <surname>Benjamin</surname>
                      <given-names>LS</given-names>
                    </name>
                  </person-group>
                  <year>1997</year>
                  <article-title>Structured Clinical Interview for DSM-IV Axis II Personality
Disorders, (SCID-II).</article-title>
                  <publisher-loc>WashingtonD.C.</publisher-loc>
                  <publisher-name>American Psychiatric Press, Inc</publisher-name>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Zanarini1">
                <label>41</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zanarini</surname>
                      <given-names>MC</given-names>
                    </name>
                    <name>
                      <surname>Frankenburg</surname>
                      <given-names>FR</given-names>
                    </name>
                  </person-group>
                  <year>2001</year>
                  <article-title>Attainment and maintenance of reliability of axis I and II
disorders over the course of a longitudinal study.</article-title>
                  <source>Compr Psychiatry</source>
                  <volume>42</volume>
                  <fpage>369</fpage>
                  <lpage>374</lpage>
                  <pub-id pub-id-type="pmid">11559863</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Maffei1">
                <label>42</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Maffei</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Fossati</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Agostoni</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Barraco</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Bagnato</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>1997</year>
                  <article-title>Interrater reliability and internal consistency of the structured
clinical interview for DSM-IV axis II personality disorders (SCID-II),
version 2.0.</article-title>
                  <source>J Pers Disord</source>
                  <volume>11</volume>
                  <fpage>279</fpage>
                  <lpage>284</lpage>
                  <pub-id pub-id-type="pmid">9348491</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Guy1">
                <label>43</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="editor">
                    <name>
                      <surname>Guy</surname>
                      <given-names>W</given-names>
                    </name>
                  </person-group>
                  <year>1976</year>
                  <article-title>Clinical Global Impressions.</article-title>
                  <publisher-loc>Rockville</publisher-loc>
                  <publisher-name>US Department of Health and Human services</publisher-name>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Borkovec1">
                <label>44</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Borkovec</surname>
                      <given-names>TD</given-names>
                    </name>
                    <name>
                      <surname>Nau</surname>
                      <given-names>SD</given-names>
                    </name>
                  </person-group>
                  <year>1972</year>
                  <article-title>Credibility of analogue therapy rationales.</article-title>
                  <source>J Behav Ther Exp Psychiatry</source>
                  <volume>3</volume>
                  <fpage>257</fpage>
                  <lpage>260</lpage>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Hedman1">
                <label>45</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hedman</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Ljótsson</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Rück</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Furmark</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Carlbring</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2010</year>
                  <article-title>Internet administration of self-report measures commonly used in
research on social anxiety disorder: A psychometric
evaluation.</article-title>
                  <source>Computers in Human Behavior</source>
                  <volume>26</volume>
                  <fpage>736</fpage>
                  <lpage>740</lpage>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Heimberg4">
                <label>46</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Heimberg</surname>
                      <given-names>RG</given-names>
                    </name>
                    <name>
                      <surname>Becker</surname>
                      <given-names>RE</given-names>
                    </name>
                  </person-group>
                  <year>2002</year>
                  <article-title>Cognitive-behavioral group therapy for social
phobia.</article-title>
                  <source>Basic mechanisms and clinical strategies</source>
                  <publisher-loc>New York</publisher-loc>
                  <publisher-name>Guilford Press</publisher-name>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Ledley1">
                <label>47</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ledley</surname>
                      <given-names>DR</given-names>
                    </name>
                    <name>
                      <surname>Heimberg</surname>
                      <given-names>RG</given-names>
                    </name>
                    <name>
                      <surname>Hope</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Hayes</surname>
                      <given-names>SA</given-names>
                    </name>
                    <name>
                      <surname>Zaider</surname>
                      <given-names>TI</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2009</year>
                  <article-title>Efficacy of a Manualized and Workbook-Driven Individual Treatment
for Social Anxiety Disorder.</article-title>
                  <source>Behav Ther</source>
                  <volume>40</volume>
                  <fpage>414</fpage>
                  <lpage>424</lpage>
                  <pub-id pub-id-type="pmid">19892086</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Clark2">
                <label>48</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Clark</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>Wells</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <year>1995</year>
                  <article-title>A cognitive model of social phobia.</article-title>
                  <person-group person-group-type="editor">
                    <name>
                      <surname>Heimberg</surname>
                      <given-names>RG</given-names>
                    </name>
                    <name>
                      <surname>Leibowitz</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Hope</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Schneider</surname>
                      <given-names>FR</given-names>
                    </name>
                  </person-group>
                  <source>Social phobia: Diagnosis, assessment and treatment</source>
                  <publisher-loc>New York</publisher-loc>
                  <publisher-name>Guilford press</publisher-name>
                  <fpage>63</fpage>
                  <lpage>93</lpage>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Hofmann1">
                <label>49</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hofmann</surname>
                      <given-names>SG</given-names>
                    </name>
                    <name>
                      <surname>Smits</surname>
                      <given-names>JA</given-names>
                    </name>
                  </person-group>
                  <year>2008</year>
                  <article-title>Cognitive-behavioral therapy for adult anxiety disorders: a
meta-analysis of randomized placebo-controlled trials.</article-title>
                  <source>J Clin Psychiatry</source>
                  <volume>69</volume>
                  <fpage>621</fpage>
                  <lpage>632</lpage>
                  <pub-id pub-id-type="pmid">18363421</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-ClarkCarter1">
                <label>50</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Clark-Carter</surname>
                      <given-names>D</given-names>
                    </name>
                  </person-group>
                  <year>1997</year>
                  <article-title>Doing quantitative psychological research- from design to
report.</article-title>
                  <publisher-loc>East Sussex</publisher-loc>
                  <publisher-name>Psychology Press</publisher-name>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Gueorguieva1">
                <label>51</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gueorguieva</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Krystal</surname>
                      <given-names>JH</given-names>
                    </name>
                  </person-group>
                  <year>2004</year>
                  <article-title>Move over ANOVA: progress in analyzing repeated-measures data and
its reflection in papers published in the Archives of General
Psychiatry.</article-title>
                  <source>Arch Gen Psychiatry</source>
                  <volume>61</volume>
                  <fpage>310</fpage>
                  <lpage>317</lpage>
                  <pub-id pub-id-type="pmid">14993119</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Jacobson1">
                <label>52</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jacobson</surname>
                      <given-names>NS</given-names>
                    </name>
                    <name>
                      <surname>Truax</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <year>1991</year>
                  <article-title>Clinical significance: A statistical approach to defining
meaningful change in psychotherapy research.</article-title>
                  <source>J Consult Clin Psychol</source>
                  <volume>59</volume>
                  <fpage>12</fpage>
                  <lpage>19</lpage>
                  <pub-id pub-id-type="pmid">2002127</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Fresco1">
                <label>53</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fresco</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>Coles</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Heimberg</surname>
                      <given-names>RG</given-names>
                    </name>
                    <name>
                      <surname>Liebowitz</surname>
                      <given-names>MR</given-names>
                    </name>
                    <name>
                      <surname>Hami</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2001</year>
                  <article-title>The Liebowitz Social Anxiety Scale: a comparison of the
psychometric properties of self-report and clinician-administered
formats.</article-title>
                  <source>Psychol Med</source>
                  <volume>31</volume>
                  <fpage>1025</fpage>
                  <lpage>1035</lpage>
                  <pub-id pub-id-type="pmid">11513370</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Heimberg5">
                <label>54</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Heimberg</surname>
                      <given-names>RG</given-names>
                    </name>
                    <name>
                      <surname>Liebowitz</surname>
                      <given-names>MR</given-names>
                    </name>
                    <name>
                      <surname>Hope</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Schneier</surname>
                      <given-names>FR</given-names>
                    </name>
                    <name>
                      <surname>Holt</surname>
                      <given-names>CS</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>1998</year>
                  <article-title>Cognitive behavioral group therapy vs phenelzine therapy for
social phobia: 12-week outcome.</article-title>
                  <source>Arch Gen Psychiatry</source>
                  <volume>55</volume>
                  <fpage>1133</fpage>
                  <lpage>1141</lpage>
                  <pub-id pub-id-type="pmid">9862558</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Yonkers1">
                <label>55</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yonkers</surname>
                      <given-names>KA</given-names>
                    </name>
                    <name>
                      <surname>Bruce</surname>
                      <given-names>SE</given-names>
                    </name>
                    <name>
                      <surname>Dyck</surname>
                      <given-names>IR</given-names>
                    </name>
                    <name>
                      <surname>Keller</surname>
                      <given-names>MB</given-names>
                    </name>
                  </person-group>
                  <year>2003</year>
                  <article-title>Chronicity, relapse, and illness - course of panic disorder,
social phobia, and generalized anxiety disorder: Findings in men and women
from 8 years of follow-up.</article-title>
                  <source>Depress Anxiety</source>
                  <volume>17</volume>
                  <fpage>173</fpage>
                  <lpage>179</lpage>
                  <pub-id pub-id-type="pmid">12768651</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Erwin1">
                <label>56</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Erwin</surname>
                      <given-names>BA</given-names>
                    </name>
                    <name>
                      <surname>Turk</surname>
                      <given-names>CL</given-names>
                    </name>
                    <name>
                      <surname>Heimberg</surname>
                      <given-names>RG</given-names>
                    </name>
                    <name>
                      <surname>Fresco</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>Hantula</surname>
                      <given-names>DA</given-names>
                    </name>
                  </person-group>
                  <year>2004</year>
                  <article-title>The Internet: home to a severe population of individuals with
social anxiety disorder?</article-title>
                  <source>J Anxiety Disord</source>
                  <volume>18</volume>
                  <fpage>629</fpage>
                  <lpage>646</lpage>
                  <pub-id pub-id-type="pmid">15275943</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Heimberg6">
                <label>57</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Heimberg</surname>
                      <given-names>RG</given-names>
                    </name>
                    <name>
                      <surname>Salzman</surname>
                      <given-names>DG</given-names>
                    </name>
                    <name>
                      <surname>Holt</surname>
                      <given-names>CS</given-names>
                    </name>
                    <name>
                      <surname>Blendell</surname>
                      <given-names>KA</given-names>
                    </name>
                  </person-group>
                  <year>1993</year>
                  <article-title>Cognitive-behavioral group treatment for social phobia:
Effectiveness at five-year followup.</article-title>
                  <source>Cognitive Ther Res</source>
                  <volume>17</volume>
                  <fpage>325</fpage>
                  <lpage>339</lpage>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Blanco1">
                <label>58</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Blanco</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Heimberg</surname>
                      <given-names>RG</given-names>
                    </name>
                    <name>
                      <surname>Schneier</surname>
                      <given-names>FR</given-names>
                    </name>
                    <name>
                      <surname>Fresco</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>H</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <year>2010</year>
                  <article-title>A Placebo-Controlled Trial of Phenelzine, Cognitive Behavioral
Group Therapy, and Their Combination for Social Anxiety
Disorder.</article-title>
                  <source>Arch Gen Psychiatry</source>
                  <volume>67</volume>
                  <fpage>286</fpage>
                  <lpage>295</lpage>
                  <pub-id pub-id-type="pmid">20194829</pub-id>
                </element-citation>
              </ref>
              <ref id="pone.0018001-Attkisson1">
                <label>59</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Attkisson</surname>
                      <given-names>CC</given-names>
                    </name>
                    <name>
                      <surname>Zwick</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <year>1982</year>
                  <article-title>The client satisfaction questionnaire. Psychometric properties
and correlations with service utilization and psychotherapy
outcome.</article-title>
                  <source>Eval Program Plann</source>
                  <volume>5</volume>
                  <fpage>233</fpage>
                  <lpage>237</lpage>
                  <pub-id pub-id-type="pmid">10259963</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
